Hangzhou Nutrition Biotechnology Co., Ltd.
Hangzhou Nutrition Biotechnology Co., Ltd. is a Chinese biotechnical exporter with a focus on collagen and enteral nutrition (EN) products for global markets. Founded in 2009 and located in Hangzhou, the company sits roughly 1.5 hours from Shanghai Pudong International Airport, providing relatively accessible logistics for international shipments. The organization operates specialized workshops for collagen production and EN products, supporting a range of product formats including bulk hydrolyzed collagen powder, fish collagen peptide, collagen granules, and EN formulations such as branched-chain amino acid blends, dietary fiber, and multivitamin powders. The business emphasizes a robust research and development capability, with its fish collagen peptide technology recognized as a key project supported by Zhejiang Province government in 2012, underscoring a commitment to ongoing innovation. Hangzhou Nutrition Biotechnology Co., Ltd. maintains certifications across quality and safety domains, having obtained QS, HACCP, ISO 22000, HALAL, and CIQ credentials, and offers original equipment manufacturing (OEM) services for various collagen product formats, including canned, stripe, satchel, capsule, tablet, and beverage types. The company reports an annual production capacity of 500 tons for fish collagen powder and 300 tons for EN products, reflecting a solid production footprint. Its products are positioned in the Chinese market through collaborations with major hospitals, such as Peking Union Medical College Hospital, West China Hospital, The First Affiliated Hospital of Sun Yat-sen University, and The Second Affiliated Hospital of Zhejiang University School of Medicine, highlighting a strong healthcare sector presence. With approximately a 15% share of the medical foods market, Hangzhou Nutrition Biotechnology Co., Ltd. anticipates future growth and expansion in its sector.
Alongside its manufacturing and R&D strengths, the company emphasizes a capability for OEM partnerships and a broad portfolio of collagen and EN offerings, supported by provincial government recognition and a track record of quality certifications. While the profile indicates a well-established domestic footprint and hospital partnerships, it does not provide detailed information on international distribution networks, freight forwarding services, or third-party logistics capabilities beyond typical export-oriented operations.
